Jennifer Whangbo
8PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 04, 2026
A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT.Muhammad Umair Mushtaq, John F DiPersio, Jacques Azzi
|Oct 23, 2025
Remission of TP53-Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33).Guenther Koehne, Muhammad U Mushtaq, Lori S Muffly
|Apr 16, 2024
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol.Sarah Nikiforow, Jennifer S Whangbo, Ran Reshef
|Aug 21, 2023
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease.Holly Wobma, Malika Kapadia, Haesook T Kim
|Jul 21, 2023
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.Roxane Labrosse, Julia I Chu, Myriam A Armant
Pageof 2
Frequent Collaborators
2 joint publications
Joseph Maakaron
2 joint publications
Giacomo Canesin
2 joint publications
Joseph C Rimando
2 joint publications
Michelle I Lin
2 joint publications
Lori S Muffly
2 joint publications
Melissa M Lee-Sundlov
2 joint publications
Nirali N Shah
2 joint publications
Jerome Ritz
2 joint publications
Francesca Alvarez-Calderon
1 joint publications
Haesook T Kim